Published in J Virol on January 01, 1999
Mutation rates among RNA viruses. Proc Natl Acad Sci U S A (1999) 6.37
Viral mutation rates. J Virol (2010) 3.87
Theory of lethal mutagenesis for viruses. J Virol (2007) 2.20
Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing. J Virol (2010) 1.75
Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72
Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol (2004) 1.29
Measurements of spontaneous rates of mutations in the recent past and the near future. Philos Trans R Soc Lond B Biol Sci (2010) 1.25
Barriers to antigenic escape by pathogens: trade-off between reproductive rate and antigenic mutability. BMC Evol Biol (2007) 1.01
Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol Biol (2004) 1.00
Invasion thresholds and the evolution of nonequilibrium virulence. Evol Appl (2008) 0.99
Observing micro-evolutionary processes of viral populations at multiple scales. Philos Trans R Soc Lond B Biol Sci (2013) 0.92
Variation in RNA virus mutation rates across host cells. PLoS Pathog (2014) 0.89
Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res (2008) 0.88
Mechanisms of viral mutation. Cell Mol Life Sci (2016) 0.85
Wild-type measles viruses with non-standard genome lengths. PLoS One (2014) 0.84
Correlation between mutation rate and genome size in riboviruses: mutation rate of bacteriophage Qβ. Genetics (2013) 0.84
Synergizing vaccinations with therapeutics for measles eradication. Expert Opin Drug Discov (2013) 0.83
Cell tropism predicts long-term nucleotide substitution rates of mammalian RNA viruses. PLoS Pathog (2014) 0.83
Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins. Cell Rep (2015) 0.82
Determination of spontaneous mutation frequencies in measles virus under nonselective conditions. J Virol (2012) 0.81
Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies. PLoS One (2013) 0.81
Identification of immunodominant neutralizing epitopes on the hemagglutinin protein of rinderpest virus. J Virol (2002) 0.78
Constraints on the Genetic and Antigenic Variability of Measles Virus. Viruses (2016) 0.77
Why does drug resistance readily evolve but vaccine resistance does not? Proc Biol Sci (2017) 0.75
Initiating a watch list for Ebola virus antibody escape mutations. PeerJ (2016) 0.75
Mutations of Bacteria from Virus Sensitivity to Virus Resistance. Genetics (1943) 165.64
Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A (1993) 5.42
RNA virus populations as quasispecies. Curr Top Microbiol Immunol (1992) 5.42
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol (1992) 3.37
Virus mutation frequencies can be greatly underestimated by monoclonal antibody neutralization of virions. J Virol (1989) 2.27
RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis (1994) 2.08
High nucleotide substitution error frequencies in clonal pools of vesicular stomatitis virus. J Virol (1989) 2.04
Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol (1997) 2.00
Extreme heterogeneity in populations of vesicular stomatitis virus. J Virol (1989) 1.95
Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology (1992) 1.89
Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89
Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J Virol (1990) 1.87
Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis (1996) 1.66
High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc Natl Acad Sci U S A (1992) 1.60
Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology (1994) 1.31
Characterization of epitopes on the measles virus hemagglutinin. Virology (1986) 1.25
Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J Virol (1995) 1.19
Idiotypes and biological activity of murine monoclonal antibodies against the hemagglutinin of measles virus. Infect Immun (1981) 0.90
Efficient propagation of measles virus in suspension cultures. J Virol (1979) 0.87
Stability of the nucleotide sequence of the phosphoprotein gene of measles virus during lytic infections. APMIS (1990) 0.86
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Molecular biology of Hendra and Nipah viruses. Microbes Infect (2001) 2.33
Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol (1988) 2.22
Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology (2004) 2.18
Expression of the gene encoding the 17-kilodalton antigen from Rickettsia rickettsii: transcription and posttranslational modification. J Bacteriol (1988) 2.14
Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology (1992) 1.89
Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol (1992) 1.87
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine (1995) 1.83
Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology (1997) 1.83
Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus. J Virol (1985) 1.75
Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74
Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis (1998) 1.73
Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis (1996) 1.66
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J Bacteriol (1987) 1.61
Sequence homology within the morbilliviruses. J Virol (1985) 1.56
Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis (1997) 1.56
Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology (1986) 1.49
Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology (2001) 1.47
Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol (2005) 1.45
New genetic group of measles virus isolated in the People's Republic of China. Virus Res (1998) 1.42
Molecular epidemiology of measles virus. Curr Top Microbiol Immunol (2009) 1.41
Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis (1998) 1.36
Molecular characterization of measles viruses isolated in Victoria, Australia, between 1973 and 1998. J Gen Virol (2000) 1.32
Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol (1993) 1.31
Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology (1994) 1.31
Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol (1993) 1.31
Risk factors for Nipah virus infection among abattoir workers in Singapore. J Infect Dis (2000) 1.23
Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J Virol (1995) 1.19
Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19
Genetic characterization of contemporary wild-type measles viruses from Vietnam and the People's Republic of China: identification of two genotypes within clade H. Virus Res (2001) 1.18
Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol (1999) 1.14
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Positive identification of a measles virus cDNA clone encoding a region of the phosphoprotein. J Virol (1984) 1.11
The diversity of measles virus in the United Kingdom, 1992-1995. J Gen Virol (1997) 1.08
Measles virus strain variations. Curr Top Microbiol Immunol (1995) 1.08
Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol (1998) 1.08
C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine (2001) 1.08
Human cellular immune response to measles virus polypeptides. J Virol (1984) 1.07
Virology of measles virus. J Infect Dis (1994) 1.06
Purification of measles virus with preservation of infectivity and antigenicity. J Gen Virol (1979) 1.06
Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis (1993) 1.05
Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. JAMA (1996) 1.05
Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis (1994) 1.05
Immune reactivity of the purified hemagglutinin of measles virus. Infect Immun (1981) 1.04
Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol (2014) 1.03
Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis (1999) 1.03
Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples. J Med Virol (2001) 1.02
Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics (1996) 1.02
Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr (1994) 1.02
Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol (2009) 1.01
Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerg Infect Dis (2001) 1.00
Monospecific antibody to the haemagglutinin of measles virus. J Gen Virol (1980) 1.00
Biosynthesis of measles virus hemagglutinin in persistently infected cells. Arch Virol (1983) 0.99
Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE. Clin Exp Immunol (1980) 0.98
Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine. J Gen Virol (1993) 0.97
Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination. Clin Diagn Lab Immunol (1998) 0.96
Measles genotype G2 in Indonesia and Malaysia. Lancet (2000) 0.96
A broad cytotoxic T lymphocyte response to influenza type B virus presented by multiple HLA molecules. Int Immunol (1997) 0.95
An evaluation of measles revaccination among school-entry-aged children. Pediatrics (1996) 0.94
Rabies diagnostic reagents prepared from a rabies N gene recombinant expressed in baculovirus. J Clin Microbiol (1990) 0.93
Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J Virol (1999) 0.92
Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection. J Virol (1991) 0.92
Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein. Virology (1991) 0.92
Characterization of cloned measles virus mRNAs by in vitro transcription, translation, and immunoprecipitation. Intervirology (1987) 0.92
Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes. Ann N Y Acad Sci (1988) 0.91
Idiotypes and biological activity of murine monoclonal antibodies against the hemagglutinin of measles virus. Infect Immun (1981) 0.90
Cloned measles virus-specific T lymphocytes from a twin with multiple sclerosis. Proc Natl Acad Sci U S A (1983) 0.90
Monitoring progress toward measles elimination by genetic diversity analysis of measles viruses in China 2009-2010. Clin Microbiol Infect (2014) 0.90
Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans. Virology (1997) 0.87
Induction of intercellular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells. J Med Virol (1999) 0.87
Negative impact of clinical misdiagnosis of measles on health workers' confidence in measles vaccine. Epidemiol Infect (2004) 0.87